Introduction of miR-3613-3p as a regulator of transforming growth factor-β (TGF-β) signaling pathway in colorectal cancer
Molecular Biology Reports · 2024
DOI: 10.1007/s11033-024-09419-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Biology Reports, 2024. Verfasst von Monireh Jafarian und 4 weiteren Autor:innen. Beteiligte Einrichtung: Genetics Department, Faculty of Biological Sciences, Tarbiat Modares University, Tehran, Iran. Hauptthemen laut MEDLINE: MicroRNAs, Colorectal Neoplasms, Signal Transduction, Transforming Growth Factor beta. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 28 Literaturangaben. Gefördert von: Tarbiat Modares University, Iran National Science Foundation.
Abstract (Originalsprache)
INTRODUCTION: Colorectal cancer (CRC) is the second common cancer and the fourth major reason of cancer death worldwide. Dysregulation of intracellular pathways, such as TGF-β/SMAD signaling, contributes to CRC development. MicroRNAs (miRNAs) are post-transcriptional regulators that are involved in CRC pathogenesis. Here, we aimed to investigate the effect of miR-3613-3p on the TGF-β /SMAD signaling pathway in CRC. METHODS & RESULTS: Bioinformatics analysis suggested that miR-3613-3p is a regulator of TGF-Β signaling downstream genes. Then, miR-3613-3p overexpression was followed by downregulation of TGF-βR1, TGF-βR2, and SMAD2 expression levels, detected by RT-qPCR. Additionally, dual luciferase assay supported the direct interaction of miR-3613-3p with 3'UTR sequences of TGF-βR1 and TGF-βR2 genes. Furthermore, reduced SMAD3 protein level following the miR-3613-3p overexpression verified its suppressive effect against TGF-β signaling in HCT-116 cells, detected by western blot analysis. Finally, miR-3613-3p overexpression induced sub-G1 arrest in HCT116 cells, detected by flow cytometry, and promoted downregulation of cyclin D1 protein expression, which was detected by western blotting analysis. CONCLUSION: Our findings indicated that miR-3613-3p plays an important role in CRC by targeting the TGF-β/SMAD signaling pathway and could be considered as a new candidate for further therapy investigations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Genetics Department, Faculty of Biological Sciences, Tarbiat Modares University, Tehran, Iran.
- Genetics Department, Faculty of Biological Sciences, Tarbiat Modares University, Tehran, Iran. soltanib@modares.ac.ir.
Förderung
- Tarbiat Modares University
- Iran National Science Foundation
Zitieren
APA
Jafarian, M., Hasannia, T., Badameh, P., Behmanesh, M., & Soltani, B. M. (2024). Introduction of miR-3613-3p as a regulator of transforming growth factor-β (TGF-β) signaling pathway in colorectal cancer. Molecular Biology Reports. https://doi.org/10.1007/s11033-024-09419-3
Vancouver
Jafarian M, Hasannia T, Badameh P, Behmanesh M, Soltani BM. Introduction of miR-3613-3p as a regulator of transforming growth factor-β (TGF-β) signaling pathway in colorectal cancer. Molecular Biology Reports. 2024. doi:10.1007/s11033-024-09419-3
BibTeX
@article{Jafarian2024,
author = {Jafarian, Monireh and Hasannia, Tabasom and Badameh, Parisa and Behmanesh, Mehrdad and Soltani, Bahram M},
title = {Introduction of miR-3613-3p as a regulator of transforming growth factor-β (TGF-β) signaling pathway in colorectal cancer},
journal = {Molecular Biology Reports},
year = {2024},
doi = {10.1007/s11033-024-09419-3}
}
EUVIMED